Diversified Trust Co boosted its stake in Waters Corporation (NYSE:WAT) by 0.4% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,285 shares of the medical instruments supplier’s stock after buying an additional 5 shares during the period. Diversified Trust Co’s holdings in Waters Corporation were worth $236,000 at the end of the most recent reporting period.
A number of other large investors have also recently bought and sold shares of the company. BlackRock Inc. boosted its stake in Waters Corporation by 2,810.7% in the first quarter. BlackRock Inc. now owns 5,349,711 shares of the medical instruments supplier’s stock valued at $836,212,000 after buying an additional 5,165,917 shares in the last quarter. Mondrian Investment Partners LTD purchased a new stake in Waters Corporation during the first quarter valued at $81,480,000. Nomura Asset Management Co. Ltd. boosted its stake in Waters Corporation by 3,735.4% in the first quarter. Nomura Asset Management Co. Ltd. now owns 373,950 shares of the medical instruments supplier’s stock valued at $58,452,000 after buying an additional 364,200 shares in the last quarter. Janus Capital Management LLC boosted its stake in Waters Corporation by 18.2% in the first quarter. Janus Capital Management LLC now owns 2,309,646 shares of the medical instruments supplier’s stock valued at $361,021,000 after buying an additional 356,395 shares in the last quarter. Finally, Fundsmith LLP boosted its stake in Waters Corporation by 11.3% in the first quarter. Fundsmith LLP now owns 3,432,535 shares of the medical instruments supplier’s stock valued at $536,540,000 after buying an additional 349,178 shares in the last quarter. 92.06% of the stock is owned by institutional investors and hedge funds.
Waters Corporation (NYSE WAT) traded up 1.60% during mid-day trading on Wednesday, reaching $182.40. 365,071 shares of the company’s stock were exchanged. Waters Corporation has a one year low of $133.35 and a one year high of $187.65. The stock has a 50-day moving average of $180.07 and a 200-day moving average of $168.55. The stock has a market cap of $14.56 billion, a price-to-earnings ratio of 27.49 and a beta of 0.84.
Waters Corporation (NYSE:WAT) last posted its earnings results on Tuesday, July 25th. The medical instruments supplier reported $1.76 earnings per share for the quarter, beating analysts’ consensus estimates of $1.71 by $0.05. Waters Corporation had a return on equity of 23.91% and a net margin of 24.26%. The company had revenue of $558.30 million for the quarter, compared to the consensus estimate of $553.22 million. During the same quarter in the prior year, the company earned $1.58 earnings per share. Waters Corporation’s revenue was up 4.0% on a year-over-year basis. On average, equities research analysts anticipate that Waters Corporation will post $7.38 earnings per share for the current year.
Waters Corporation declared that its board has authorized a share repurchase plan on Thursday, May 11th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the medical instruments supplier to reacquire up to 7.3% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company’s board believes its shares are undervalued.
COPYRIGHT VIOLATION WARNING: This report was originally published by BBNS and is the property of of BBNS. If you are reading this report on another site, it was illegally copied and republished in violation of international copyright and trademark legislation. The correct version of this report can be read at https://baseballnewssource.com/markets/diversified-trust-co-acquires-5-shares-of-waters-corporation-wat-updated-updated-updated/1253672.html.
Several equities research analysts recently weighed in on WAT shares. Morgan Stanley reaffirmed an “underweight” rating and set a $183.00 price objective (up previously from $174.00) on shares of Waters Corporation in a research report on Wednesday, July 26th. Janney Montgomery Scott raised shares of Waters Corporation from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $185.00 to $200.00 in a research report on Monday, May 1st. Deutsche Bank AG reissued a “buy” rating and issued a $183.00 target price (up previously from $166.00) on shares of Waters Corporation in a report on Saturday, April 29th. Jefferies Group LLC reissued a “hold” rating and issued a $170.00 target price on shares of Waters Corporation in a report on Friday, July 14th. Finally, Cowen and Company increased their target price on shares of Waters Corporation from $160.00 to $175.00 and gave the stock a “market perform” rating in a report on Wednesday, April 26th. Two investment analysts have rated the stock with a sell rating, five have given a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $186.00.
In other Waters Corporation news, SVP Rohit Khanna sold 23,000 shares of the stock in a transaction dated Friday, June 9th. The stock was sold at an average price of $186.90, for a total value of $4,298,700.00. Following the transaction, the senior vice president now owns 27,077 shares of the company’s stock, valued at $5,060,691.30. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, SVP Michael C. Harrington sold 24,000 shares of the stock in a transaction dated Friday, May 19th. The shares were sold at an average price of $175.33, for a total value of $4,207,920.00. Following the completion of the transaction, the senior vice president now directly owns 28,073 shares in the company, valued at approximately $4,922,039.09. The disclosure for this sale can be found here. In the last three months, insiders sold 98,580 shares of company stock worth $17,730,275. 5.07% of the stock is owned by corporate insiders.
Waters Corporation Company Profile
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with our FREE daily email newsletter.